Chapter 35: Men?s Health Drugs - Nurselytic

Questions 12

ATI LPN

ATI LPN TextBook-Based Test Bank

Pharmacology and the Nursing Process 10th Edition Test Bank

Chapter 35 : Men?s Health Drugs Questions

Question 1 of 5

The nurse is instructing a male patient about application of transdermal testosterone gel. Which body location is preferred for this medication? (Select all that apply.)

Correct Answer: A,D,E

Rationale: Transdermal testosterone gel (AndroGel) is applied to the shoulders, upper arms, or abdomen for optimal absorption. The scrotum and thigh are not recommended application sites.

Question 2 of 5

A patient will be receiving testosterone cypionate 400 mg intramuscularly every 4 weeks. The medication is available in a 200-mg/mL strength. Identify how many milliliters will the nurse draw up for each injection.

Correct Answer: 2 mL

Rationale:
To calculate: 200 mg/1 mL = 400 mg/x mL. Cross-multiply: (200 * x) = (1 * 400); 200x = 400; x = 400/200 = 2 mL.

Question 3 of 5

A patient is to receive testosterone therapy via a transdermal patch. He asks the nurse, 'I'd rather take a pill. Why am I getting a patch?' Which response by the nurse is correct?

Correct Answer: C

Rationale: Transdermal testosterone patches provide better absorption due to bypassing the high first-pass metabolism of oral forms. Patches are changed daily, not weekly, and do not necessarily reduce side effects or mandate injections as the only alternative.

Question 4 of 5

When a male patient is receiving androgen therapy, the nurse will monitor for signs of excessive androgens such as

Correct Answer: A

Rationale: Excessive androgens can cause fluid retention as an adverse effect, leading to edema or weight gain. Dehydration, restlessness, and visual changes are not typical effects of androgen excess.

Question 5 of 5

A patient is receiving finasteride for treatment of benign prostatic hyperplasia. The nurse will tell him that a possible effect of this medication is

Correct Answer: B

Rationale: Finasteride, a 5-alpha-reductase inhibitor, reduces prostate size in benign prostatic hyperplasia and can promote hair growth as a side effect, often used for male pattern baldness. It does not cause alopecia, urinary retention, or prostate enlargement.

Access More Questions!

ATI LPN Basic


$89/ 30 days

 

ATI LPN Premium


$150/ 90 days

 

Similar Questions